Abstract
Cardiac transplantation has been used since 1968 to restore cardiac function in selected patients with otherwise unmanageable heart disease. In these recipients successful outcome of the procedure has been highly dependent upon effective management of allograft rejection using immunosuppressive agents. Prior to 1980 these agents included Azathioprine, corticosteroids and antithymocyte globulin — ATG (conventional therapy). In 1980 cyclosporin A, a fungal product whose therapeutic effect appears to result from its ability to block allograft directed T cell cytotoxic responses while leaving intact T cell suppressoV responses, was substituted for azathioprine in the conventional therapy regimen (cyclosporin A therapy) (1,2). Although outcome of transplantation has been favorably effected in patients treated with cyclosporin A (79% one year survival vs. 63% in conventionally treated recipients) morbidity due to lymphoma has increased.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Oyer, P.E., Stinson, E.B., Jamieson, S.W., Hunt, S.A., Billingham, M., Scott, W., Bieber, C.P, Reitz, B.A., and Humway, N.E. Cyclosporin A in cardiac allografting: a preliminary experience. Transpl. Proc., in press.
Hess, A.D. and Tutschka, P.J. Effect of Cyclosporin A on human lymphocyte responses in vitro. J. Immunol., 124:2601, 1980.
Bieber, C.P., Hunt, S.A., Schwinn, D.A., Jamieson, S.W., Reitz, B.A., Oyer, P.E., Shumway, N.E., and Stinson, E.B. Complications in long-term survivors of cardiac transplantation. Transpl. Proc, 13:207, 1981.
Pennock, J.L., Oyer, P.E., Reitz, B.A., Jamieson, S.W., Bieber, C.P., Wallwork, J., Stinson, E.B., and Shumway, N.E. Cardiac transplantation in prospective for the future. J. Thorac. and Cardio. Surg., 83:168, 1982.
Weintraub, J. and Warnke, R.A. Lymphoma in cardiac allotransplant recipients. Clinical and histologic features in immunologic phenotype. Transplant., 33:347, 1982.
Frizzera, G., Hanto, D., Kazmiera, J., Gajl-Peczalska, J., Rosai, J., McKenna, R.W., Sibley, R.K., Holahan, K.P., and Lindquist, L.L. Polymorphic diffuse B cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res., 41:4262, 1981.
Saemundsen, A.K., Klein, G., Cleary, M., and Warnke, R. EBV-carrying lymphoma in cardiac transplant recipients. Lancet, ii:158, 1982.
Henle, W., Henle, G., Zajac, B., Pearson, G., Waubke, R., and Scriba, M. Differential reactivity of human sera with EBV-induced “early antigens.” Science, 169:188, 1970.
Saemundsen, A.K., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Synnerholm, A.C., Hanto, D.W., Simmons, R.L., Anvret, M., Collins, R., and Klein, G. Documentation of EB virus infections in immunodeficient patients with life-threatening lymphoproliferative diseases by EB virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res., 41:4237, 1981.
Bieber, C.P., Pennock, J.L., and Reitz, B.A. Lymphoma in Cyclosporin A treated non human primate allograft recipients in malignant lymphomas. In: H.S. Kaplan and S. Rosenberg, p. 219. New York: Academic Press, 1982.
Heberling, R.L., Bieber, C.P., and Kalter, S.S. Establishment of a lymphoblastoid cell line from a lymphoraatous Cynomolgus monkey. In: D.S. Yohn and J.R. Blakeslee (eds.), Advances in Comparative Leukemia Research. pp. 385–386. Amsterdam: Elsevier Biomedical, 1982.
Calne, R.Y., Rolles, K., and Thiru, S. Cyclosporin initially as the only immunosuppressant in 34 recipients of cadaveric organs. Lancet, ii:1033, 1979.
Crawford, D.H., Thomas, J.A., and Janossy, G. Epstein-Barr virus nuclear antigen positive lymphoma after Cyclosporin A treatment in patients with renal allograft. Lancet, i:1355, 1980.
Crawford, D.H., Sweeny, P., Edwards, J.N., Janossy, G., and Hoffbrand, A.V. Long-term T cell-mediated immunity to EB virus in renal allograft recipients receiving Cyclosporin A. Lancet, i:10, 1981.
Bird, A.G., McLachlan, S.M., and Britton, S. Cyclosporin A promotes spontaneous outgrowth in vitro in EB virus induced B cell lines. Nature, 289:300, 1981.
Prieksaiks, J. — Personal communication.
Hanto, D.W., Frizzera, G., Gajl-Peczalska, J., Purtilo, D.T., Klein, G., Simmons, R.L., and Najarian, J.S. The EB virus in the pathogenesis of posttransplant lymphoma. Transplant. Proc, 13:756, 1981.
Epstein, M.A. Vaccine control of EB virus-associated tumors in the.Epstein-Barr virus. In: M.A. Epstein, and B.G. Achong (eds.), The Epstein-Barr Virus. pp. 440–448. Berlin, Heidelberg, New York: Springer-Verlag, 1979.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Publishing Corporation
About this chapter
Cite this chapter
Bieber, C.P. et al. (1984). Lymphoma in Cardiac Transplant Recipients Associated with Cyclosporin A, Prednisone and Anti-Thymocyte Globulin (ATG). In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4760-6_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4762-0
Online ISBN: 978-1-4684-4760-6
eBook Packages: Springer Book Archive